Loading clinical trials...
Loading clinical trials...
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes
This proposal will test if, in patients with type 1 diabetes, wide blood glucose fluctuations lead to the injury to heart nerves , called cardiac autonomic neuropathy (CAN), and to impaired heart contractile (pumping) function and heart failure. It will also evaluate the natural history of heart failure and enhanced cardiac risk in patients with type 1 diabetes in the current standard of diabetes care.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
Yes
University Of Michigan
Ann Arbor, Michigan, United States
Start Date
May 1, 2010
Primary Completion Date
August 1, 2016
Completion Date
August 1, 2016
Last Updated
August 27, 2018
55
ESTIMATED participants
Lead Sponsor
University of Michigan
NCT07051005
NCT06390371
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03228732